Efficacy and Safety of Lornoxicam in Patients With Acute Coronary Syndrome (PLEA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00997750
Recruitment Status : Completed
First Posted : October 19, 2009
Last Update Posted : October 19, 2009
Information provided by:
Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2008
  Study Completion Date : June 2009
Lomakin N.V., Gruzdev A.K. Cardiovascular risks of cyclooxygenase inhibitors (data review). Kardiol serdecno-sosud hir #1:28-36, 2009 (